China SXT Pharmaceuticals, Inc. Made Headway

Fri, Apr 25, 2025 at 07:59 PM

China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) soared at $2.29, representing a gain of 44.9%. On Fri, Apr 25, 2025, SXTC:NASDAQ touched a New 2-Week Intraday High of $2.98. The stock appeared on our News Catalysts scanner on Sat, Mar 29, 2025 at 01:05 AM in the 'INSIDER' category. From Fri, Apr 11, 2025, the stock recorded 44.44% Up Days and 30.00% Green Days

The stock spiked on Tue, Apr 22, 2025 at $3.22 with a volume of 115M+.

About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)

China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.

Top 10 Gainers:

WW International, Inc. (WW:NASDAQ), 168.02%
Odyssey Marine Exploration, Inc. (OMEX:NASDAQ), 77.21%
Baijiayun Group Ltd Ord Cl A (RTC:NASDAQ), 75.42%
Urgent.ly Inc. (ULY:NASDAQ), 66.09%
Greenidge Generation Holdings Inc. (GREE:NASDAQ), 56.29%
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 44.94%
Jaguar Health, Inc. (JAGX:NASDAQ), 33.87%
Northann Corp. (NCL:NYSEMKT), 32.43%
SAIHEAT Ltd Ord Cl A (SAIH:NASDAQ), 27.78%
Vicarious Surgical Inc. Class A (RBOT:NYSE), 27.37%